The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
Listen to expert discussion focused on key topics and the latest publications by ERS, including from the European Respiratory Journal and ERS Monograph series.
Latest
ERS Monograph: Lung Diseases and Cancer
In the latest instalment of the ERS Monograph podcast series, early career representative Holly Keir talks to co-Guest Editor Kwun M. Fong about the latest ERS Monograph, covering the bidirectional relationship between Lung Diseases and Cancer.
The latest instalment of the ERS Monograph podcast series features a conversation between Editorial Board member Holly Keir and James H. Hull, one of the Guest Editors of the Monograph on Complex Breathlessness.
Cryobiopsy versus genomic classifier: a hot topic in ILDs
Prof. Katerina Antoniou is joined by Prof. Venerino Poletti and Prof. Ganesh Raghu to discuss a hot topic in Interstitial Lung Diseases - cryobiopsy versus genomic classifier.
Towards a good asthma diagnosis in adults: recent guidelines from the ERS
Prof. Florence Schleich is joined by Prof. Omar Usmani and Dr. Iñigo Ojanguren Arranz to discuss the recent ERS guidelines “Towards a good asthma diagnosis in adults” and how the diagnosis of asthma remains a challenge.
“One of the major motivations of this Monograph was to involve several specialities in order to provide the broadest overview of the manifestations of sarcoidosis”
In the latest instalment of the ERS Monograph podcast series, Editorial Board member Sheila Ramjug talks to Francesco Bonella and Daniel Culver, co-Guest Editors of the Monograph on Sarcoidosis. In an engaging conversation about this fascinating, chameleonic disease, Francesco and Daniel discuss multidisciplinary collaboration, advances of the last 10 years, areas of possible underdiagnosis and, importantly, the future. It is a conversation that really highlights how this Monograph is “an opportunity to grow the field."
This ERS podcast, hosted by ERS Advocacy Council Chair Arzu Yorgancioğlu, discusses the relationship between climate change and asthma.
The panel, made up of health professionals and patient advocates, discuss the idea of the ‘Green Asthma Patient’ and not only how climate change may impact asthma, but how asthma care may impact climate change.
"A one-stop-shop for a better understanding of this important cell and all the diseases associated with it"
ERS Monograph early career representative Sheila Ramjug talks to David J. Jackson and Michael Wechsler about their Monograph, Eosinophilic Lung Diseases. In a conversation covering eosinophil types and the way they work, the safety of eosinophil depletion, key chapters and important questions for the future, David and Michael explain why this Monograph is relevant to everyone, both junior and senior physicians and scientists alike.
“Suddenly, I find myself involved in research and clinical care in a disease I hadn’t even heard about 2 ½ years ago”
In a conversation that really encapsulates the pandemic rollercoaster we continue to live through, Guest Editors Aurelie Fabre, John Hurst and Sheila Ramjug discuss the importance of the ERS Monograph on COVID-19, providing as it does a comprehensive review of all areas of the disease. This podcast is a fascinating listen for researchers and clinicians from both within and beyond respiratory medicine, and will even appeal to the lay listener. The podcast covers the incentives behind a COVID Monograph, standout chapters, the positives that can be drawn from the pandemic and the importance of collaboration: “a reflection of how much we can achieve when we work as one”.
The evolving role of blood eosinophil counts in COPD
In the latest ERS Podcast, Dave Singh, Mona Bafadhel and Alberto Papi disucuss the evolving role of blood eosinophil counts in COPD. Blood eosinophil counts are an established biomarker in chronic obstructive pulmonary disease, helping to direct appropriate use of inhaled corticosteroids. Despite considerable evidence supporting the use of eosinophil counts in clinical practice, this is a controversial topic that has divided opinions. This podcast will cover the evidence and the controversies, and dissect new information concerning the role of eosinophils in chronic obstructive pulmonary disease.
Treatment of drug-susceptible and drug-resistant TB: where we are and where we go
In the latest ERS Podcast Moderator Giovanni Battista Migliori is joined by Simon Tiberi and Onno Akkerman to discuss the new available options to reduce the treatment duration for drug-susceptible patients to 4 months and for MDR-TB patients to 6 months by discussing the important ongoing trials. The speakers also discuss the ideal organization of a clinical department to ensure adequate infection control and the modern approach to monitor the blood levels of anti-TB drugs.
Disclaimer from Simon Tiberi: I am an employee of GSK. The opinions shared in this podcast are my own and not the views of my employer.
In the latest instalment of the ERS Monograph podcast series, Editorial Board member Sheila Ramjug talks to Anne Holland, Professor of Physiotherapy at Monash University and Guest Editor of the Monograph on Pulmonary Rehabilitation. Their broad-ranging discussion covers everything from balancing a home life with a career in medicine, to the impact of COVID-19 on implementing pulmonary rehabilitation. Anne talks about the origins of pulmonary rehabilitation, the need to better personalise patient care, and recommends chapters that will help readers understand the patient experience and that provide practical tips on establishing a rehabilitation programme.
Prof. Mirjam Stahl and Prof. Stojka Fustik are joined by Prof. Marcus Mall to discuss CFTR modulators, the current hot topic area of cystic fibrosis, and how CFTR modulators therapy has developed over the past decades.
Long term antibiotic treatments for chronic lung disease
Professor James Chalmers is joined by Professors Jodie Simpson and Wisia Wedzicha to discuss the role of prophylactic antibiotic treatment in the prevention of exacerbations. They review current evidence from randomised trials, demonstrating the effect of long-term antibiotic treatment on exacerbation rates and symptoms in asthma, COPD, bronchiectasis and other diseases...
ERS Monograph: Respiratory Diseases of the Newborn Infant
"In terms of preventing them coming to your clinic, the only thing we can do is focus on the early years."
The lasting impact of respiratory health in the early years, pre-birth and even pre-conception forms the focus of earnest and warm discussion in this latest fascinating Monograph podcast. Ian P. Sinha and Jayesh Mahendra Bhatt, Guest Editors of Respiratory Diseases of the Newborn Infant, talk to Sheila Ramjug about what attracted them to the field, the reasons behind the Monograph’s compilation and its importance to non-paediatric respiratory physicians, the impact of socioeconomic status on lung health and the devastating effects of child poverty.
Prof. Refika Hamutcu Ersu is joined by Prof. Stijn Verhulst to discuss topics relating to morbidity in the obese child with obstructive sleep apnoea, including why obesity is relevant to OSA, the use of continuous positive airway pressure non-invasive ventilation, and the role of weight loss as a therapy...
Asthma diagnosis in children: lessons learnt from the ERS task force
Professor Sejal Saglani is joined by Professor Erol Gaillard to discuss the recent ERS Task Force on the diagnosis of asthma in children and the reason behind it’s development.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.